{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Ultra-Long-Acting Insulins: A Review of Efficacy,Safety, and Implications for Practice

Purpose of Activity

To provide information on the clinical properties, dosing, packaging and place in therapy of ultralong acting insulins.

Learning Objectives/Outcomes

After completing this continuing education activity you will be able to:

  1. Describe the pharmacodynamics of insulin glargine U100, U300, and insulin degludec.
  2. Describe the benefits of long acting insulins in clinical practice.
  3. Determine proper dosing of long acting insulins in clinical practice.
Price: $17.95


  • AANP 1.5 CH / 1.5 APH
  • DC - BON 1.5 CH
  • FL - BON 1.5 CH
  • GA - BON 1.5 CH

This Activity is approved for 1.5 contact hour (s) of continuing education (which includes 1.5 hour(s) pharmacology) by the American Association of Nurse Practitioners. Activity ID# 18033125. This Activity was planned in accordance with AANP Accreditation Standards and Policies.

Awarded Advanced Pharmacology Hours

Test Code: JAANP0718
Published: Jul 2018
Expires: 7/1/2019
Passing Score: 13/18 (72%)
Authors: Courtney S. Davis, PharmD, BCACP; Joshua W. Fleming, PharmD, BCACP; Scott S. Malinowski, PharmD; Meagan A. Brown, PharmD, BCACP; Laurie W. Fleming, PharmD, BC-ADM, BCACP